UTC Alumnus Authors Hydroxychloroquine Study in New England Journal of Medicine
June 30, 2020
June 30, 2020
CHATTANOOGA, Tennessee, June 30 -- The University of Tennessee's Chattanooga Campus issued the following news release:
The prescription drug hydroxychloroquine has been in the news in recent months, thanks to the COVID-19 global pandemic.
Hydroxychloroquine has been used successfully to treat lupus and rheumatoid arthritis and to prevent and treat malaria by killing the parasites that cause that disease. Since the drug has been beneficial in fighting off other vira . . .
The prescription drug hydroxychloroquine has been in the news in recent months, thanks to the COVID-19 global pandemic.
Hydroxychloroquine has been used successfully to treat lupus and rheumatoid arthritis and to prevent and treat malaria by killing the parasites that cause that disease. Since the drug has been beneficial in fighting off other vira . . .